Skip to content
Wenlo
Sign in
← Markets

Aytu BioPharma, Inc.

Aytu BioPharma, Inc. (AYTU) — Form DEF 14A: Proxy statement

DEF 14AAYTUFiled Oct 22, 2026, 12:30 PM ET· Period Dec 10, 2026

About this filing

Aytu BioPharma, Inc. (AYTU) filed Form DEF 14A (proxy statement) with the SEC on Oct 22, 2026.

Key facts

Document
FORM DEF 14A

More AYTU filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.